Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2017 | GHSD HD18 study: reducing chemotherapy toxicity in advanced stage Hodgkin lymphoma

Press brief by Peter Borchmann, MD from the University Hospital Cologne, Germany at the European Hematology Association (EHA) 2017 meeting, held in Madrid, Spain.